Citations 898

AV‐1451 tau and β‐amyloid positron emission tomography imaging in dementia with Lewy bodies

Annals of Neurology | November 19, 2016 | Volume: 81 | Issue: 1 | Pages: 58-67

10.1002/ana.24825 | PMID 27863444

ObjectivePatients with probable dementia with Lewy bodies (DLB) often have Alzheimer's disease (AD)‐related pathology. Our objective was to determine the pattern of positron emission tomography (PET) tau tracer AV‐1451 uptake in patients with probable DLB, compared to AD, and its relationship to β‐amyloid deposition on PET.MethodsConsecutive patients with clinically probable DLB (n = 19) from the Mayo Clinic Alzheimer's Disease Research Center underwent magnetic resonance imaging, AV‐1451, and Pittsburgh compound‐B (PiB) PET examinations. Age‐ and sex‐matched groups of AD dementia (n = 19) patients and clinically normal controls (n = 95) from an epidemiological cohort served as a comparison groups. Atlas‐ and voxel‐based analyses were performed.ResultsThe AD dementia group had significantly higher AV‐1451 uptake than the probable DLB group, and medial temporal uptake completely distinguished AD dementia from probable DLB. Patients with probable DLB had greater AV‐1451 uptake in the posterior temporoparietal and occipital cortex compared to clinically normal controls, and in probable DLB, the uptake in these regions correlated with global cortical PiB uptake (Spearman rho = 0.63; p = 0.006).InterpretationMedial temporal lobe AV‐1451 uptake distinguishes AD dementia from probable DLB, which may be useful for differential diagnosis. Elevated posterior temporoparietal and occipital AV‐1451 uptake in probable DLB and its association with global cortical PiB uptake suggest an atypical pattern of tau deposition in DLB. ANN NEUROL 2017;81:58–67
Hippocampal volumes predict risk of dementia with Lewy bodies in mild cognitive impairment

Neurology | November 2, 2016 | Volume: 87 | Issue: 22 | Pages: 2317-2323

10.1212/wnl.0000000000003371 | PMID 27807186

P4‐201: Cortical Microinfarcts and Regional Gray Matter Loss on Antemortem MRI

Alzheimer's & Dementia | October 17, 2016 | Volume: 12 | Issue: 7S_Part_22 | Pages: No page available

10.1016/j.jalz.2016.06.2294

P3‐255: PET TAU Imaging with AV‐1451 in Microtubule‐Associated Protein TAU (MAPT) Mutation Carriers Relative to Alzheimer’S Disease Dementia and Controls

Alzheimer's & Dementia | October 17, 2016 | Volume: 12 | Issue: 7S_Part_19 | Pages: No page available

10.1016/j.jalz.2016.06.1918

P2‐178: Amyloid‐B, Neuropsychiatric Symptoms and the Risk of Incident Mild Cognitive Impairment: The Mayo Clinic Study of Aging

Alzheimer's & Dementia | October 17, 2016 | Volume: 12 | Issue: 7S_Part_14 | Pages: No page available

10.1016/j.jalz.2016.06.1345

P2‐201: Pathologic Predictors of Disease Duration in Lewy Body Disease

Alzheimer's & Dementia | October 17, 2016 | Volume: 12 | Issue: 7S_Part_14 | Pages: No page available

10.1016/j.jalz.2016.06.1369

P2‐248: Neuropsychological and MRI Findings in MAPT Mutation Carriers in the Evolution from the Asymptomatic to Symptomatic State

Alzheimer's & Dementia | October 17, 2016 | Volume: 12 | Issue: 7S_Part_14 | Pages: No page available

10.1016/j.jalz.2016.06.1416

P1‐247: Network‐Based TAU Deposition Patterns are Related to Functional Network Failure Largely Via Beta‐Amyloid Across the Alzheimer’s Spectrum

Alzheimer's & Dementia | October 17, 2016 | Volume: 12 | Issue: 7S_Part_10 | Pages: No page available

10.1016/j.jalz.2016.06.996

O2‐08‐01: Av1451 Pet Imaging in the Spectrum of Alzheimer's Disease from Clinically Normal to Dementia

Alzheimer's & Dementia | October 17, 2016 | Volume: 12 | Issue: 7S_Part_5 | Pages: No page available

10.1016/j.jalz.2016.06.436

IC‐P‐180: PET TAU Imaging With AV‐1451 in Microtubule Associated Protein TAU (MAPT) Mutation Carriers Relative to Alzheimer’s Disease Dementia and Controls

Alzheimer's & Dementia | October 17, 2016 | Volume: 12 | Issue: 7S_Part_2 | Pages: No page available

10.1016/j.jalz.2016.06.211